首页 > 最新文献

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease最新文献

英文 中文
Predictors of Survival in Patients With Ischemic Stroke and Active Cancer: A Prospective, Multicenter, Observational Study 缺血性脑卒中和活动性癌症患者的生存预测因素:一项前瞻性、多中心、观察性研究
Pub Date : 2023-05-10 DOI: 10.1101/2023.05.08.23289699
Y. Gon, M. Sakaguchi, H. Yamagami, Soichiro Abe, H. Hashimoto, N. Ohara, D. Takahashi, Yuko Abe, Tsutomu Takahashi, T. Kitano, Shuhei Okazaki, K. Todo, Tsutomu Sasaki, Satoshi Hattori, H. Mochizuki
Background: Patients with ischemic stroke and active cancer have a poor prognosis; however, supporting evidence remains limited. Methods: We conducted a prospective, multicenter, observational study in Japan including patients with acute ischemic stroke and active cancer to investigate the prognostic factors. We followed up the patients for 1 year after stroke onset. The patients were divided into two groups according to cryptogenic stroke and known etiologies (small vessel occlusion, large artery atherosclerosis, cardioembolism, other determined etiology) and survival was compared. The hazard ratios (HRs) and 95% confidence intervals (CIs) for mortality were calculated using Cox regression models. Results: We identified 135 eligible patients (39% women; median age, 75 years). Of these, 51% had distant metastasis. A total of 65 (48%) and 70 (52%) patients had cryptogenic stroke and known etiologies, respectively. Patients with cryptogenic stroke had significantly shorter survival than those with known etiologies (HR [95% CI], 3.11 [1.82-5.25]). The multivariate Cox regression analysis revealed that distant metastasis, plasma D-dimer levels, deep venous thrombosis and/or pulmonary embolism complications at stroke onset were independent predictors of mortality after adjusting for potential confounders. Cryptogenic stroke was associated with prognosis in univariate analysis but not significant in multivariate analysis. The plasma D-dimer levels stratified the prognosis of patients with ischemic stroke and active cancer. Conclusions: The prognosis of patients with acute ischemic stroke and active cancer varies considerably depending on stroke mechanism, distant metastasis, and coagulation abnormalities. Coagulation abnormalities are crucial in determining the prognosis of such patients.
背景:缺血性脑卒中合并活动性肿瘤患者预后较差;然而,支持证据仍然有限。方法:我们在日本进行了一项前瞻性、多中心、观察性研究,包括急性缺血性脑卒中和活动性癌症患者,以探讨预后因素。我们在患者中风后随访1年。根据隐源性卒中和已知病因(小血管闭塞、大动脉粥样硬化、心脏栓塞、其他确定病因)将患者分为两组,比较生存率。采用Cox回归模型计算死亡率的风险比(hr)和95%置信区间(CIs)。结果:我们确定了135例符合条件的患者(39%为女性;中位年龄,75岁)。其中51%有远处转移。共有65例(48%)和70例(52%)患者分别患有隐源性卒中和已知病因。隐源性卒中患者的生存期明显短于已知病因的患者(HR [95% CI], 3.11[1.82-5.25])。多因素Cox回归分析显示,在调整潜在混杂因素后,卒中发病时远处转移、血浆d -二聚体水平、深静脉血栓形成和/或肺栓塞并发症是死亡率的独立预测因素。在单因素分析中,隐源性卒中与预后相关,但在多因素分析中不显著。血浆d -二聚体水平对缺血性脑卒中和活动性癌症患者的预后有分层作用。结论:急性缺血性脑卒中和活动性肿瘤患者的预后与脑卒中机制、远处转移和凝血功能异常有关。凝血异常是决定这类患者预后的关键因素。
{"title":"Predictors of Survival in Patients With Ischemic Stroke and Active Cancer: A Prospective, Multicenter, Observational Study","authors":"Y. Gon, M. Sakaguchi, H. Yamagami, Soichiro Abe, H. Hashimoto, N. Ohara, D. Takahashi, Yuko Abe, Tsutomu Takahashi, T. Kitano, Shuhei Okazaki, K. Todo, Tsutomu Sasaki, Satoshi Hattori, H. Mochizuki","doi":"10.1101/2023.05.08.23289699","DOIUrl":"https://doi.org/10.1101/2023.05.08.23289699","url":null,"abstract":"Background: Patients with ischemic stroke and active cancer have a poor prognosis; however, supporting evidence remains limited. Methods: We conducted a prospective, multicenter, observational study in Japan including patients with acute ischemic stroke and active cancer to investigate the prognostic factors. We followed up the patients for 1 year after stroke onset. The patients were divided into two groups according to cryptogenic stroke and known etiologies (small vessel occlusion, large artery atherosclerosis, cardioembolism, other determined etiology) and survival was compared. The hazard ratios (HRs) and 95% confidence intervals (CIs) for mortality were calculated using Cox regression models. Results: We identified 135 eligible patients (39% women; median age, 75 years). Of these, 51% had distant metastasis. A total of 65 (48%) and 70 (52%) patients had cryptogenic stroke and known etiologies, respectively. Patients with cryptogenic stroke had significantly shorter survival than those with known etiologies (HR [95% CI], 3.11 [1.82-5.25]). The multivariate Cox regression analysis revealed that distant metastasis, plasma D-dimer levels, deep venous thrombosis and/or pulmonary embolism complications at stroke onset were independent predictors of mortality after adjusting for potential confounders. Cryptogenic stroke was associated with prognosis in univariate analysis but not significant in multivariate analysis. The plasma D-dimer levels stratified the prognosis of patients with ischemic stroke and active cancer. Conclusions: The prognosis of patients with acute ischemic stroke and active cancer varies considerably depending on stroke mechanism, distant metastasis, and coagulation abnormalities. Coagulation abnormalities are crucial in determining the prognosis of such patients.","PeriodicalId":17189,"journal":{"name":"Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease","volume":"54 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74120218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of Slow‐Flow After Primary Percutaneous Coronary Intervention With Flow‐Mediated Hyperemia: The Randomized RAIN‐FLOW Study 经皮冠状动脉介入治疗后血流介导充血的慢血流治疗:随机RAIN - Flow研究
Pub Date : 2023-02-24 DOI: 10.1101/2023.02.21.23286266
J. Gómez-Lara, M. Gracida, F. Rivero, A. Gutiérrez-Barrios, Guillem Muntané-Carol, R. Romaguera, L. Fuentes, Ana Marcano, G. Roura, J. Ferreiro, L. Teruel, S. Brugaletta, F. Alfonso, J. Comín-Colet, J. Gomez-Hospital
Background: ST-segment Elevation Myocardial Infarction (STEMI) complicated with no reflow after primary percutaneous coronary intervention is associated with adverse outcomes. Although several hyperemic drugs have shown to improve the Thrombolysis In Myocardial Infarction (TIMI) flow, optimal treatment of no reflow remains unsettled. Saline infusion at 20 ml/min via a dedicated microcatheter causes (flow-mediated) hyperemia. The objective is to compare the efficacy of pharmacologic vs. flow-mediated hyperemia in STEMI patients complicated with no reflow. Methods: STEMI patients with no reflow were randomized to receive either adenosine or nitroprusside vs. flow-mediated hyperemia. The angiographic corrected TIMI Frame Count (cTFC) and the Minimal Microcirculatory Resistance (MMR), as assessed with intracoronary pressure-thermistor wire, dedicated microcatheter and thermodilution techniques, were compared after study interventions. Results: Sixty-seven were included (30 allocated to pharmacologic and 37 to flow-mediated hyperemia). After study interventions, cTFC (40.2{+/-}23.1 vs. 39.2{+/-} 20.7; p=0.858) and MMR (753.6{+/-}661.5 vs. 993.3{+/-}740.8 Wood units; p=0.174) were similar between groups. TIMI 3 flow was observed in 26.7% vs. 27.0% (p=0.899). Flow-mediated hyperemia showed two different thermodilution patterns during saline infusion indicative of the severity of the no reflow phenomenon. In-hospital death and non-fatal heart failure were observed in 10.4% and 26.9%, respectively. Conclusions: Both treatments showed similar (and limited) efficacy restoring coronary flow. Flow-mediated hyperemia with thermodilution pattern assessment allowed the simultaneous characterization of the no reflow degree and response to hyperemia. No reflow was associated with a high rate of adverse outcomes. Further research is warranted to prevent and to treat no reflow in STEMI patients (NCT04685941).
背景:经皮冠状动脉介入治疗后st段抬高型心肌梗死(STEMI)合并无再流与不良结局相关。虽然一些充血药物已被证明可以改善心肌梗死(TIMI)血流,但无血流的最佳治疗方法仍未确定。通过专用微导管以20ml /min的速度输注生理盐水会引起(血流介导的)充血。目的是比较药物治疗与血流介导充血治疗STEMI合并无血流的疗效。方法:没有再流的STEMI患者随机接受腺苷或硝普苷与血流介导的充血。在研究干预后,比较经血管造影校正的TIMI框架计数(cTFC)和最小微循环阻力(MMR),通过冠状动脉内压力热敏电阻丝、专用微导管和热稀释技术进行评估。结果:纳入67例(30例分配给药理学组,37例分配给血流性充血组)。研究干预后,cTFC (40.2{+/-}23.1 vs. 39.2{+/-} 20.7;p = 0.858)和MMR (661.5 vs 993.3 753.6{+ / -}{+ / -} 740.8木单位;P =0.174),组间相似。timi3血流发生率为26.7% vs. 27.0% (p=0.899)。在生理盐水输注期间,血流介导的充血表现出两种不同的热稀释模式,表明无血流现象的严重程度。院内死亡和非致死性心力衰竭发生率分别为10.4%和26.9%。结论:两种治疗方法恢复冠状动脉血流的效果相似(且有限)。血流介导的充血与热调节模式评估可以同时表征无血流程度和充血反应。无血流倒流与高不良预后率相关。需要进一步的研究来预防和治疗STEMI患者的无再流(NCT04685941)。
{"title":"Treatment of Slow‐Flow After Primary Percutaneous Coronary Intervention With Flow‐Mediated Hyperemia: The Randomized RAIN‐FLOW Study","authors":"J. Gómez-Lara, M. Gracida, F. Rivero, A. Gutiérrez-Barrios, Guillem Muntané-Carol, R. Romaguera, L. Fuentes, Ana Marcano, G. Roura, J. Ferreiro, L. Teruel, S. Brugaletta, F. Alfonso, J. Comín-Colet, J. Gomez-Hospital","doi":"10.1101/2023.02.21.23286266","DOIUrl":"https://doi.org/10.1101/2023.02.21.23286266","url":null,"abstract":"Background: ST-segment Elevation Myocardial Infarction (STEMI) complicated with no reflow after primary percutaneous coronary intervention is associated with adverse outcomes. Although several hyperemic drugs have shown to improve the Thrombolysis In Myocardial Infarction (TIMI) flow, optimal treatment of no reflow remains unsettled. Saline infusion at 20 ml/min via a dedicated microcatheter causes (flow-mediated) hyperemia. The objective is to compare the efficacy of pharmacologic vs. flow-mediated hyperemia in STEMI patients complicated with no reflow. Methods: STEMI patients with no reflow were randomized to receive either adenosine or nitroprusside vs. flow-mediated hyperemia. The angiographic corrected TIMI Frame Count (cTFC) and the Minimal Microcirculatory Resistance (MMR), as assessed with intracoronary pressure-thermistor wire, dedicated microcatheter and thermodilution techniques, were compared after study interventions. Results: Sixty-seven were included (30 allocated to pharmacologic and 37 to flow-mediated hyperemia). After study interventions, cTFC (40.2{+/-}23.1 vs. 39.2{+/-} 20.7; p=0.858) and MMR (753.6{+/-}661.5 vs. 993.3{+/-}740.8 Wood units; p=0.174) were similar between groups. TIMI 3 flow was observed in 26.7% vs. 27.0% (p=0.899). Flow-mediated hyperemia showed two different thermodilution patterns during saline infusion indicative of the severity of the no reflow phenomenon. In-hospital death and non-fatal heart failure were observed in 10.4% and 26.9%, respectively. Conclusions: Both treatments showed similar (and limited) efficacy restoring coronary flow. Flow-mediated hyperemia with thermodilution pattern assessment allowed the simultaneous characterization of the no reflow degree and response to hyperemia. No reflow was associated with a high rate of adverse outcomes. Further research is warranted to prevent and to treat no reflow in STEMI patients (NCT04685941).","PeriodicalId":17189,"journal":{"name":"Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease","volume":"124 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88007298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting Arterial Thrombotic Events Following Peripheral Revascularization Using Objective Viscoelastic Data 用客观粘弹性数据预测外周血运重建术后动脉血栓事件
M. Majumdar, Ryan P. Hall, Zach M. Feldman, Guillaume Goudot, Natalie Sumetsky, Samuel Jessula, Amanda Kirshkaln, Tiffany R. Bellomo, D. Chang, J. Cardenas, R. Patell, M. Eagleton, A. Dua
Background Peripheral artery disease is endemic in our globally aging population, with >200 million affected worldwide. Graft/stent thrombosis after revascularization is common and frequently results in amputation, major adverse cardiovascular events, and cardiovascular mortality. Optimizing medications to decrease thrombosis is of paramount importance; however, limited guidance exists on how to use and monitor antithrombotic therapy in this heterogeneous population. Thromboelastography with platelet mapping (TEG‐PM) provides comprehensive coagulation metrics and may be integral to the next stage of patient‐centered thrombophrophylaxis. This prospective study aimed to determine if TEG‐PM could predict subacute graft/stent thrombosis following lower extremity revascularization, and if objective cut point values could be established to identify those high‐risk patients. Methods and Results We conducted a single‐center prospective observational study of patients undergoing lower extremity revascularization. Patients were followed up for the composite end point postoperative graft/stent thrombosis at 1 year. TEG‐PM analysis of the time point before thrombosis in the event group was compared with the last postoperative visit in the nonevent group. Cox proportional hazards analysis examined the association of TEG‐PM metrics to thrombosis. Cut point analysis explored the predictive capacity of TEG‐PM metrics for those at high risk. A total of 162 patients were analyzed, of whom 30 (18.5%) experienced graft/stent thrombosis. Patients with thrombosis had significantly greater platelet aggregation (79.7±15.7 versus 58.5±26.4) and lower platelet inhibition (20.7±15.6% versus 41.1±26.6%) (all P<0.01). Cox proportional hazards analysis revealed that for every 1% increase in platelet aggregation, the hazard of experiencing an event during the study period increased by 5% (hazard ratio, 1.05 [95% CI, 1.02–1.07]; P<0.01). An optimal cut point of >70.8% platelet aggregation and/or <29.2% platelet inhibition identifies those at high risk of thrombosis with 87% sensitivity and 70% to 71% specificity. Conclusions Among patients undergoing lower extremity revascularization, increased platelet reactivity was predictive of subacute postoperative graft/stent thrombosis. On the basis of the cut points of >70.8% platelet aggregation and <29.2% platelet inhibition, consideration of an alternative or augmented antithrombotic regimen for high‐risk patients may decrease the risk of postoperative thrombotic events.
外周动脉疾病是全球老龄化人口的地方病,全球有2亿人受到影响。血管重建术后移植物/支架血栓形成是常见的,经常导致截肢、主要不良心血管事件和心血管死亡率。优化药物以减少血栓形成是至关重要的;然而,关于如何在这一异质人群中使用和监测抗血栓治疗的指导有限。血小板制图的血栓弹性成像(TEG - PM)提供了全面的凝血指标,可能是下一阶段以患者为中心的血栓预防的组成部分。这项前瞻性研究旨在确定TEG - PM是否可以预测下肢血运重建术后的亚急性移植物/支架血栓形成,以及是否可以建立客观的切点值来识别那些高风险患者。方法和结果我们对接受下肢血运重建术的患者进行了一项单中心前瞻性观察研究。随访1年观察术后移植/支架复合终点血栓形成情况。将事件组血栓形成前时间点的TEG - PM分析与非事件组的最后一次术后就诊进行比较。Cox比例风险分析检验了TEG - PM指标与血栓形成的关系。切点分析探讨了TEG - PM指标对高危人群的预测能力。共分析162例患者,其中30例(18.5%)发生移植物/支架血栓形成。血栓患者血小板聚集明显增加(79.7±15.7 vs 58.5±26.4),血小板抑制明显降低(20.7±15.6% vs 41.1±26.6%)(血小板聚集均为P70.8%和/或70.8%血小板聚集和血小板抑制<29.2%),对高危患者考虑替代或增强抗栓方案可能降低术后血栓事件的风险。
{"title":"Predicting Arterial Thrombotic Events Following Peripheral Revascularization Using Objective Viscoelastic Data","authors":"M. Majumdar, Ryan P. Hall, Zach M. Feldman, Guillaume Goudot, Natalie Sumetsky, Samuel Jessula, Amanda Kirshkaln, Tiffany R. Bellomo, D. Chang, J. Cardenas, R. Patell, M. Eagleton, A. Dua","doi":"10.1182/blood-2022-164832","DOIUrl":"https://doi.org/10.1182/blood-2022-164832","url":null,"abstract":"Background Peripheral artery disease is endemic in our globally aging population, with >200 million affected worldwide. Graft/stent thrombosis after revascularization is common and frequently results in amputation, major adverse cardiovascular events, and cardiovascular mortality. Optimizing medications to decrease thrombosis is of paramount importance; however, limited guidance exists on how to use and monitor antithrombotic therapy in this heterogeneous population. Thromboelastography with platelet mapping (TEG‐PM) provides comprehensive coagulation metrics and may be integral to the next stage of patient‐centered thrombophrophylaxis. This prospective study aimed to determine if TEG‐PM could predict subacute graft/stent thrombosis following lower extremity revascularization, and if objective cut point values could be established to identify those high‐risk patients. Methods and Results We conducted a single‐center prospective observational study of patients undergoing lower extremity revascularization. Patients were followed up for the composite end point postoperative graft/stent thrombosis at 1 year. TEG‐PM analysis of the time point before thrombosis in the event group was compared with the last postoperative visit in the nonevent group. Cox proportional hazards analysis examined the association of TEG‐PM metrics to thrombosis. Cut point analysis explored the predictive capacity of TEG‐PM metrics for those at high risk. A total of 162 patients were analyzed, of whom 30 (18.5%) experienced graft/stent thrombosis. Patients with thrombosis had significantly greater platelet aggregation (79.7±15.7 versus 58.5±26.4) and lower platelet inhibition (20.7±15.6% versus 41.1±26.6%) (all P<0.01). Cox proportional hazards analysis revealed that for every 1% increase in platelet aggregation, the hazard of experiencing an event during the study period increased by 5% (hazard ratio, 1.05 [95% CI, 1.02–1.07]; P<0.01). An optimal cut point of >70.8% platelet aggregation and/or <29.2% platelet inhibition identifies those at high risk of thrombosis with 87% sensitivity and 70% to 71% specificity. Conclusions Among patients undergoing lower extremity revascularization, increased platelet reactivity was predictive of subacute postoperative graft/stent thrombosis. On the basis of the cut points of >70.8% platelet aggregation and <29.2% platelet inhibition, consideration of an alternative or augmented antithrombotic regimen for high‐risk patients may decrease the risk of postoperative thrombotic events.","PeriodicalId":17189,"journal":{"name":"Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease","volume":"56 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73804187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Safety of Catheter Ablation Therapy for Atrial Fibrillation in Cardiac Amyloidosis 心脏淀粉样变性心房颤动导管消融治疗的安全性
Pub Date : 2022-11-08 DOI: 10.1161/circ.146.suppl_1.10321
H. Alhassan, A. Kainat, J. Donohue, S. Baumgartner, Harriet S. Akunor, S. Saba, Sandeep K Jain, P. Soman
Background Despite the high burden of atrial fibrillation in cardiac amyloidosis (CA), the safety of catheter ablation therapy in CA is not well established. We sought to examine short‐term safety outcomes following atrial fibrillation ablation in patients with CA compared with matched patients with dilated cardiomyopathy (DCM). Methods and Results Using data from the National Inpatient Sample, we identified all hospitalizations for atrial fibrillation ablation from the fourth quarter of 2015 through 2019. Admissions for CA and DCM were matched in a 1:5 ratio using propensity scores based on the following sociodemographics: age, sex, race or ethnicity, payor, median income, comorbidities, and hospital characteristics. We compared in‐hospital outcomes between both cardiomyopathies. We identified 1395 unweighted hospitalizations (representing 6750 national hospitalizations) for atrial fibrillation ablation, out of which 45 (3.2%) were admissions for CA. Compared with DCM, patients with CA were older (72.9 versus 65.1 years), had a higher burden of prior stroke (20.0% versus 8.6%) and chronic kidney disease (53.3% versus 33.6%), and were less likely to have a prior implantable cardioverter‐defibrillator (4.4% versus 23.0%). We successfully matched 42 CAs to 210 DCM hospitalizations. After matching, there was no difference in total complications (14.3% versus 10.5%, P=0.60), length‐of‐stay (3.1 versus 2.1 days, P=0.23), home disposition (97.6% versus 96.2%, P=0.65), and total charges ($137 250 versus $133 910, P=0.24). Conclusions In this nationally representative study of atrial fibrillation catheter ablation in CA, short‐term safety outcomes and complication rates were similar to a propensity score‐matched cohort of DCM. Further studies exploring long‐term safety outcomes are needed.
背景:尽管心脏淀粉样变性(CA)患者心房颤动的负担很高,但导管消融治疗CA的安全性尚未得到很好的确定。我们试图将CA患者心房颤动消融后的短期安全性结果与匹配的扩张型心肌病(DCM)患者进行比较。方法和结果使用来自全国住院患者样本的数据,我们确定了2015年第四季度至2019年所有因房颤消融而住院的患者。使用基于以下社会人口统计学的倾向得分,以1:5的比例匹配CA和DCM入院:年龄、性别、种族或民族、付款人、收入中位数、合并症和医院特征。我们比较了两种心肌病的住院结果。我们确定了1395例房颤消融未加权住院(代表全国6750例住院),其中45例(3.2%)为房颤住院。与DCM相比,房颤患者年龄较大(72.9岁对65.1岁),既往卒中负担较高(20.0%对8.6%)和慢性肾脏疾病负担较高(53.3%对33.6%),既往植入心律转复除颤器的可能性较小(4.4%对23.0%)。我们成功地将42例ca与210例DCM住院相匹配。配对后,总并发症(14.3%对10.5%,P=0.60)、住院时间(3.1对2.1天,P=0.23)、家庭安置(97.6%对96.2%,P=0.65)和总费用(137250美元对133910美元,P=0.24)均无差异。结论:在这项具有全国代表性的房颤导管消融研究中,短期安全性结果和并发症发生率与倾向评分匹配的DCM队列相似。需要进一步的研究来探索长期的安全性结果。
{"title":"Safety of Catheter Ablation Therapy for Atrial Fibrillation in Cardiac Amyloidosis","authors":"H. Alhassan, A. Kainat, J. Donohue, S. Baumgartner, Harriet S. Akunor, S. Saba, Sandeep K Jain, P. Soman","doi":"10.1161/circ.146.suppl_1.10321","DOIUrl":"https://doi.org/10.1161/circ.146.suppl_1.10321","url":null,"abstract":"Background Despite the high burden of atrial fibrillation in cardiac amyloidosis (CA), the safety of catheter ablation therapy in CA is not well established. We sought to examine short‐term safety outcomes following atrial fibrillation ablation in patients with CA compared with matched patients with dilated cardiomyopathy (DCM). Methods and Results Using data from the National Inpatient Sample, we identified all hospitalizations for atrial fibrillation ablation from the fourth quarter of 2015 through 2019. Admissions for CA and DCM were matched in a 1:5 ratio using propensity scores based on the following sociodemographics: age, sex, race or ethnicity, payor, median income, comorbidities, and hospital characteristics. We compared in‐hospital outcomes between both cardiomyopathies. We identified 1395 unweighted hospitalizations (representing 6750 national hospitalizations) for atrial fibrillation ablation, out of which 45 (3.2%) were admissions for CA. Compared with DCM, patients with CA were older (72.9 versus 65.1 years), had a higher burden of prior stroke (20.0% versus 8.6%) and chronic kidney disease (53.3% versus 33.6%), and were less likely to have a prior implantable cardioverter‐defibrillator (4.4% versus 23.0%). We successfully matched 42 CAs to 210 DCM hospitalizations. After matching, there was no difference in total complications (14.3% versus 10.5%, P=0.60), length‐of‐stay (3.1 versus 2.1 days, P=0.23), home disposition (97.6% versus 96.2%, P=0.65), and total charges ($137 250 versus $133 910, P=0.24). Conclusions In this nationally representative study of atrial fibrillation catheter ablation in CA, short‐term safety outcomes and complication rates were similar to a propensity score‐matched cohort of DCM. Further studies exploring long‐term safety outcomes are needed.","PeriodicalId":17189,"journal":{"name":"Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease","volume":"20 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78051877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcatheter Aortic Valve Implantation With and Without Resheathing and Repositioning: A Systematic Review and Meta-analysis. 经导管主动脉瓣植入术伴或不伴复位:一项系统综述和荟萃分析。
Pub Date : 2022-06-21 Epub Date: 2022-06-14 DOI: 10.1161/JAHA.121.024707
Francesco Moroni, Lorenzo Azzalini, Lars Sondergaard, Guilherme F Attizzani, Santiago García, Hani Jneid, Mamas A Mamas, Rodrigo Bagur

Background There is a concern that resheathing/repositioning of transcatheter heart valves during transcatheter aortic valve implantation (TAVI) may lead to an increased risk of periprocedural complications. We aimed to evaluate the short- and long-term impact on clinical outcomes of resheathing for repositioning of transcatheter heart valves during TAVI procedures. Methods and Results We conducted a systematic search of Embase, MEDLINE, and Cochrane Central Register of Controlled Trials databases to identify studies comparing outcomes between patients requiring resheathing/repositioning during TAVI and those who did not. Random-effects meta-analyses were used to estimate the association of resheathing compared with no resheathing with clinical outcomes after TAVI. Seven studies including 4501 participants (pooled mean age, 80.9±7.4 years; 54% women; and 1374 [30.5%] patients requiring resheathing/repositioning) were included in this study. No significant differences between the 2 groups were identified with regards to safety: 30-day mortality (n=3125; odds ratio [OR], 0.74 [95% confidence interval [CI], 0.41-1.33]; I2=0%), stroke (n=4121; OR, 1.09 [95% CI, 0.74-1.62]; I2=0%), coronary obstruction (n=3000; OR, 2.35 [95% CI, 0.17-33.47]; I2=75%), major vascular complications (n=3125; OR, 0.92 [95% CI, 0.66-1.33]; I2=0%), major bleeding (n=3125; OR, 1.13 [95% CI, 0.94-2.01]; I2=39%), acute kidney injury (n=3495; OR, 1.30 [95% CI, 0.64-2.62]; I2=44%), and efficacy outcomes: device success (n=1196; OR, 0.77 [95% CI, 0.51-1.14]; I2=0%), need for a second valve (n=3170; OR, 2.86 [95% CI, 0.96-8.48]; I2=62%), significant (moderate or higher) paravalvular leak (n=1151; OR, 1.53 [95% CI, 0.83-2.80]; I2=0%), and permanent pacemaker implantation (n=1908; OR, 1.04 [95% CI, 0.68-1.57]; I2=58%). One-year mortality was similar between groups (n=1972; OR, 1.00 [95% CI, 0.68-1.47]; I2=0%). Conclusions Resheathing of transcatheter heart valves during TAVI is associated with similar periprocedural risk compared with no resheathing in several patient-important outcomes. These data support the safety of current self-expanding transcatheter heart valves with resheathing features. Registration URL: https://www.crd.york.ac.uk/prospero/; Unique identifier: CRD42021273715.

研究背景:经导管主动脉瓣植入术(TAVI)中,经导管心脏瓣膜的换套/重新定位可能导致围手术期并发症的风险增加。我们的目的是评估在TAVI手术过程中,经导管心脏瓣膜重新定位的修复对临床结果的短期和长期影响。方法和结果我们对Embase、MEDLINE和Cochrane中央对照试验注册数据库进行了系统检索,以确定在TAVI期间需要和不需要重新定位的患者之间比较结果的研究。随机效应荟萃分析用于估计TAVI后,与未进行翻修相比,翻修与临床结果的关系。7项研究纳入4501名受试者(合并平均年龄80.9±7.4岁;54%的女性;1374例(30.5%)患者需要重新植皮/重新定位。两组在安全性方面无显著差异:30天死亡率(n=3125;优势比[OR], 0.74[95%可信区间[CI], 0.41-1.33];I2=0%),行程(n=4121;Or为1.09 [95% ci, 0.74-1.62];I2=0%),冠状动脉阻塞(n=3000;Or为2.35 [95% ci, 0.17-33.47];I2=75%),主要血管并发症(n=3125;Or为0.92 [95% ci, 0.66-1.33];I2=0%),大出血(n=3125;Or为1.13 [95% ci, 0.94-2.01];I2=39%),急性肾损伤(n=3495;Or为1.30 [95% ci, 0.64-2.62];I2=44%),以及疗效结局:器械成功(n=1196;Or为0.77 [95% ci, 0.51-1.14];I2=0%),需要第二个阀门(n=3170;Or为2.86 [95% ci, 0.96-8.48];I2=62%),显著(中度或更高)瓣旁漏(n=1151;Or为1.53 [95% ci, 0.83-2.80];I2=0%),永久起搏器植入(n=1908;Or为1.04 [95% ci, 0.68-1.57];I2 = 58%)。两组间一年死亡率相似(n=1972;Or为1.00 [95% ci, 0.68-1.47];I2 = 0%)。结论:经导管心脏瓣膜置换术与不置换术相比,在TAVI中有相似的围手术期风险。这些数据支持目前具有修复功能的自膨胀经导管心脏瓣膜的安全性。注册网址:https://www.crd.york.ac.uk/prospero/;唯一标识符:CRD42021273715。
{"title":"Transcatheter Aortic Valve Implantation With and Without Resheathing and Repositioning: A Systematic Review and Meta-analysis.","authors":"Francesco Moroni, Lorenzo Azzalini, Lars Sondergaard, Guilherme F Attizzani, Santiago García, Hani Jneid, Mamas A Mamas, Rodrigo Bagur","doi":"10.1161/JAHA.121.024707","DOIUrl":"10.1161/JAHA.121.024707","url":null,"abstract":"<p><p>Background There is a concern that resheathing/repositioning of transcatheter heart valves during transcatheter aortic valve implantation (TAVI) may lead to an increased risk of periprocedural complications. We aimed to evaluate the short- and long-term impact on clinical outcomes of resheathing for repositioning of transcatheter heart valves during TAVI procedures. Methods and Results We conducted a systematic search of Embase, MEDLINE, and Cochrane Central Register of Controlled Trials databases to identify studies comparing outcomes between patients requiring resheathing/repositioning during TAVI and those who did not. Random-effects meta-analyses were used to estimate the association of resheathing compared with no resheathing with clinical outcomes after TAVI. Seven studies including 4501 participants (pooled mean age, 80.9±7.4 years; 54% women; and 1374 [30.5%] patients requiring resheathing/repositioning) were included in this study. No significant differences between the 2 groups were identified with regards to safety: 30-day mortality (n=3125; odds ratio [OR], 0.74 [95% confidence interval [CI], 0.41-1.33]; <i>I</i><sup>2</sup>=0%), stroke (n=4121; OR, 1.09 [95% CI, 0.74-1.62]; <i>I</i><sup>2</sup>=0%), coronary obstruction (n=3000; OR, 2.35 [95% CI, 0.17-33.47]; <i>I</i><sup>2</sup>=75%), major vascular complications (n=3125; OR, 0.92 [95% CI, 0.66-1.33]; <i>I</i><sup>2</sup>=0%), major bleeding (n=3125; OR, 1.13 [95% CI, 0.94-2.01]; <i>I</i><sup>2</sup>=39%), acute kidney injury (n=3495; OR, 1.30 [95% CI, 0.64-2.62]; <i>I</i><sup>2</sup>=44%), and efficacy outcomes: device success (n=1196; OR, 0.77 [95% CI, 0.51-1.14]; <i>I</i><sup>2</sup>=0%), need for a second valve (n=3170; OR, 2.86 [95% CI, 0.96-8.48]; <i>I</i><sup>2</sup>=62%), significant (moderate or higher) paravalvular leak (n=1151; OR, 1.53 [95% CI, 0.83-2.80]; <i>I</i><sup>2</sup>=0%), and permanent pacemaker implantation (n=1908; OR, 1.04 [95% CI, 0.68-1.57]; <i>I</i><sup>2</sup>=58%). One-year mortality was similar between groups (n=1972; OR, 1.00 [95% CI, 0.68-1.47]; <i>I</i><sup>2</sup>=0%). Conclusions Resheathing of transcatheter heart valves during TAVI is associated with similar periprocedural risk compared with no resheathing in several patient-important outcomes. These data support the safety of current self-expanding transcatheter heart valves with resheathing features. Registration URL: https://www.crd.york.ac.uk/prospero/; Unique identifier: CRD42021273715.</p>","PeriodicalId":17189,"journal":{"name":"Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease","volume":"13 1","pages":"e024707"},"PeriodicalIF":0.0,"publicationDate":"2022-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238664/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87440705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Altered Cerebral Microstructure in Adults With Atrial Septal Defect and Ventricular Septal Defect Repaired in Childhood. 成人房间隔缺损和儿童期室间隔缺损修复的大脑微结构改变。
Pub Date : 2022-06-21 Epub Date: 2022-06-14 DOI: 10.1161/JAHA.121.020915
Benjamin Asschenfeldt, Lars Evald, Camilla Salvig, Johan Heiberg, Leif Østergaard, Simon Fristed Eskildsen, Vibeke Elisabeth Hjortdal

Background Delayed brain development, brain injury, and neurodevelopmental disabilities are commonly observed in infants operated for complex congenital heart defect. Our previous findings of poorer neurodevelopmental outcomes in individuals operated for simple congenital heart defects calls for further etiological clarification. Hence, we examined the microstructural tissue composition in cerebral cortex and subcortical structures in comparison to healthy controls and whether differences were associated with neurodevelopmental outcomes. Methods and Results Adults (n=62) who underwent surgical closure of an atrial septal defect (n=33) or a ventricular septal defect (n=29) in childhood and a group of healthy, matched controls (n=38) were enrolled. Brain diffusional kurtosis imaging and neuropsychological assessment were performed. Cortical and subcortical tissue microstructure were assessed using mean kurtosis tensor and mean diffusivity and compared between groups and tested for associations with neuropsychological outcomes. Alterations in microstructural tissue composition were found in the parietal, temporal, and occipital lobes in the congenital heart defects, with distinct mean kurtosis tensor cluster-specific changes in the right visual cortex (pericalcarine gyrus, P=0.002; occipital part of fusiform and lingual gyri, P=0.019). Altered microstructural tissue composition in the subcortical structures was uncovered in atrial septal defects but not in ventricular septal defects. Associations were found between altered cerebral microstructure and social recognition and executive function. Conclusions Children operated for simple congenital heart defects demonstrated altered microstructural tissue composition in the cerebral cortex and subcortical structures during adulthood when compared with healthy peers. Alterations in cerebral microstructural tissue composition were associated with poorer neuropsychological performance. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT03871881.

背景复杂先天性心脏缺损手术后的婴儿脑发育迟缓、脑损伤和神经发育障碍是常见的。我们之前的研究发现,单纯性先天性心脏缺陷患者的神经发育结果较差,这需要进一步的病因澄清。因此,我们研究了与健康对照组相比,大脑皮层和皮层下结构的微结构组织组成,以及这些差异是否与神经发育结果有关。方法和结果在儿童时期接受过房间隔缺损(n=33)或室间隔缺损(n=29)手术的成人(n=62)和一组健康匹配的对照组(n=38)被纳入研究。进行脑弥漫性峰度成像和神经心理评估。使用平均峰度张量和平均扩散率评估皮层和皮层下组织微观结构,比较各组之间的差异,并测试其与神经心理结果的关联。先天性心脏缺损患者的顶叶、颞叶和枕叶的微结构组织组成发生改变,右侧视觉皮层有明显的平均峰度张量簇特异性改变(骨膜回,P=0.002;枕部梭状回和舌回,P=0.019)。在房间隔缺损中发现皮层下结构组织组成的改变,但在室间隔缺损中没有发现。发现大脑微观结构的改变与社会认知和执行功能之间存在关联。结论单纯性先天性心脏缺损患儿在成年期大脑皮层和皮层下结构的显微组织组成与健康同龄人相比发生了改变。大脑微结构组织组成的改变与较差的神经心理表现有关。注册网址:https://www.clinicaltrials.gov;唯一标识符:NCT03871881。
{"title":"Altered Cerebral Microstructure in Adults With Atrial Septal Defect and Ventricular Septal Defect Repaired in Childhood.","authors":"Benjamin Asschenfeldt, Lars Evald, Camilla Salvig, Johan Heiberg, Leif Østergaard, Simon Fristed Eskildsen, Vibeke Elisabeth Hjortdal","doi":"10.1161/JAHA.121.020915","DOIUrl":"10.1161/JAHA.121.020915","url":null,"abstract":"<p><p>Background Delayed brain development, brain injury, and neurodevelopmental disabilities are commonly observed in infants operated for complex congenital heart defect. Our previous findings of poorer neurodevelopmental outcomes in individuals operated for simple congenital heart defects calls for further etiological clarification. Hence, we examined the microstructural tissue composition in cerebral cortex and subcortical structures in comparison to healthy controls and whether differences were associated with neurodevelopmental outcomes. Methods and Results Adults (n=62) who underwent surgical closure of an atrial septal defect (n=33) or a ventricular septal defect (n=29) in childhood and a group of healthy, matched controls (n=38) were enrolled. Brain diffusional kurtosis imaging and neuropsychological assessment were performed. Cortical and subcortical tissue microstructure were assessed using mean kurtosis tensor and mean diffusivity and compared between groups and tested for associations with neuropsychological outcomes. Alterations in microstructural tissue composition were found in the parietal, temporal, and occipital lobes in the congenital heart defects, with distinct mean kurtosis tensor cluster-specific changes in the right visual cortex (pericalcarine gyrus, <i>P</i>=0.002; occipital part of fusiform and lingual gyri, <i>P</i>=0.019). Altered microstructural tissue composition in the subcortical structures was uncovered in atrial septal defects but not in ventricular septal defects. Associations were found between altered cerebral microstructure and social recognition and executive function. Conclusions Children operated for simple congenital heart defects demonstrated altered microstructural tissue composition in the cerebral cortex and subcortical structures during adulthood when compared with healthy peers. Alterations in cerebral microstructural tissue composition were associated with poorer neuropsychological performance. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT03871881.</p>","PeriodicalId":17189,"journal":{"name":"Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease","volume":"70 14","pages":"e020915"},"PeriodicalIF":0.0,"publicationDate":"2022-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238637/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91485947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends, Predictors, and Outcomes of Cardiovascular Complications Associated With Polycystic Ovary Syndrome During Delivery Hospitalizations: A National Inpatient Sample Analysis (2002–2019) 分娩住院期间与多囊卵巢综合征相关的心血管并发症的趋势、预测因素和结果:2002-2019年全国住院患者样本分析
S. Zahid, M. Khan, S. Gowda, N. Faza, M. Honigberg, A. Vaught, C. Guan, A. Minhas, E. Michos
Background Women with polycystic ovary syndrome (PCOS) have an increased risk of pregnancy‐associated complications. However, data on peripartum cardiovascular complications remain limited. Hence, we investigated trends, outcomes, and predictors of cardiovascular complications associated with PCOS diagnosis during delivery hospitalizations in the United States. Methods and Results We used data from the National Inpatient Sample (2002–2019). International Classification of Diseases, Ninth Revision (ICD‐9), or International Classification of Diseases, Tenth Revision (ICD‐10), codes were used to identify delivery hospitalizations and PCOS diagnosis. A total of 71 436 308 weighted hospitalizations for deliveries were identified, of which 0.3% were among women with PCOS (n=195 675). The prevalence of PCOS, and obesity among those with PCOS, increased during the study period. Women with PCOS were older (median, 31 versus 28 years; P<0.01) and had a higher prevalence of diabetes, obesity, and dyslipidemia. After adjustment for age, race and ethnicity, comorbidities, insurance, and income, PCOS remained an independent predictor of cardiovascular complications, including preeclampsia (adjusted odds ratio [OR], 1.56 [95% CI, 1.54–1.59]; P<0.01), eclampsia (adjusted OR, 1.58 [95% CI, 1.54–1.59]; P<0.01), peripartum cardiomyopathy (adjusted OR, 1.79 [95% CI, 1.49–2.13]; P<0.01), and heart failure (adjusted OR, 1.76 [95% CI, 1.27–2.45]; P<0.01), compared with no PCOS. Moreover, delivery hospitalizations among women with PCOS were associated with increased length (3 versus 2 days; P<0.01) and cost of hospitalization ($4901 versus $3616; P<0.01). Conclusions Women with PCOS had a higher risk of preeclampsia/eclampsia, peripartum cardiomyopathy, and heart failure during delivery hospitalizations. Moreover, delivery hospitalizations among women with PCOS diagnosis were associated with increased length and cost of hospitalization. This signifies the importance of prepregnancy consultation and optimization for cardiometabolic health to improve maternal and neonatal outcomes.
背景:患有多囊卵巢综合征(PCOS)的女性发生妊娠相关并发症的风险增加。然而,关于围产期心血管并发症的数据仍然有限。因此,我们调查了美国分娩住院期间与PCOS诊断相关的心血管并发症的趋势、结果和预测因素。方法与结果我们使用了2002-2019年全国住院患者样本的数据。《国际疾病分类》第九版(ICD‐9)或《国际疾病分类》第十版(ICD‐10)使用编码来识别分娩住院情况和多囊卵巢综合征诊断。共确定了71 436 308例分娩加权住院,其中0.3%为多囊卵巢综合征妇女(n=195 675)。在研究期间,多囊卵巢综合征的患病率以及多囊卵巢综合征患者的肥胖发生率均有所上升。多囊卵巢综合征患者年龄较大(中位数,31岁vs 28岁;P<0.01),糖尿病、肥胖和血脂异常的患病率较高。在对年龄、种族、合并症、保险和收入进行校正后,PCOS仍然是心血管并发症的独立预测因子,包括先兆子痫(校正优势比[OR], 1.56 [95% CI, 1.54-1.59];P<0.01),子痫(校正OR, 1.58 [95% CI, 1.54-1.59];P<0.01),围产期心肌病(校正OR, 1.79 [95% CI, 1.49-2.13];P<0.01)和心力衰竭(校正OR为1.76 [95% CI, 1.27-2.45];P<0.01)。此外,多囊卵巢综合征(PCOS)妇女的分娩住院时间与分娩时间增加有关(3天对2天;P<0.01)和住院费用(4901美元对3616美元;P < 0.01)。结论PCOS患者在分娩住院期间发生子痫前期/子痫、围产期心肌病和心力衰竭的风险较高。此外,诊断为多囊卵巢综合征的妇女分娩住院与住院时间和住院费用增加有关。这表明孕前咨询和优化心脏代谢健康对改善孕产妇和新生儿结局的重要性。
{"title":"Trends, Predictors, and Outcomes of Cardiovascular Complications Associated With Polycystic Ovary Syndrome During Delivery Hospitalizations: A National Inpatient Sample Analysis (2002–2019)","authors":"S. Zahid, M. Khan, S. Gowda, N. Faza, M. Honigberg, A. Vaught, C. Guan, A. Minhas, E. Michos","doi":"10.1161/JAHA.121.025839","DOIUrl":"https://doi.org/10.1161/JAHA.121.025839","url":null,"abstract":"Background Women with polycystic ovary syndrome (PCOS) have an increased risk of pregnancy‐associated complications. However, data on peripartum cardiovascular complications remain limited. Hence, we investigated trends, outcomes, and predictors of cardiovascular complications associated with PCOS diagnosis during delivery hospitalizations in the United States. Methods and Results We used data from the National Inpatient Sample (2002–2019). International Classification of Diseases, Ninth Revision (ICD‐9), or International Classification of Diseases, Tenth Revision (ICD‐10), codes were used to identify delivery hospitalizations and PCOS diagnosis. A total of 71 436 308 weighted hospitalizations for deliveries were identified, of which 0.3% were among women with PCOS (n=195 675). The prevalence of PCOS, and obesity among those with PCOS, increased during the study period. Women with PCOS were older (median, 31 versus 28 years; P<0.01) and had a higher prevalence of diabetes, obesity, and dyslipidemia. After adjustment for age, race and ethnicity, comorbidities, insurance, and income, PCOS remained an independent predictor of cardiovascular complications, including preeclampsia (adjusted odds ratio [OR], 1.56 [95% CI, 1.54–1.59]; P<0.01), eclampsia (adjusted OR, 1.58 [95% CI, 1.54–1.59]; P<0.01), peripartum cardiomyopathy (adjusted OR, 1.79 [95% CI, 1.49–2.13]; P<0.01), and heart failure (adjusted OR, 1.76 [95% CI, 1.27–2.45]; P<0.01), compared with no PCOS. Moreover, delivery hospitalizations among women with PCOS were associated with increased length (3 versus 2 days; P<0.01) and cost of hospitalization ($4901 versus $3616; P<0.01). Conclusions Women with PCOS had a higher risk of preeclampsia/eclampsia, peripartum cardiomyopathy, and heart failure during delivery hospitalizations. Moreover, delivery hospitalizations among women with PCOS diagnosis were associated with increased length and cost of hospitalization. This signifies the importance of prepregnancy consultation and optimization for cardiometabolic health to improve maternal and neonatal outcomes.","PeriodicalId":17189,"journal":{"name":"Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84207401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Development and Validation of 3‐Year Atrial Fibrillation Prediction Models Using Electronic Health Record With or Without Standardized Electrocardiogram Diagnosis and a Performance Comparison Among Models 基于电子健康记录的3年房颤预测模型的开发和验证,有或没有标准化的心电图诊断和模型之间的性能比较
Yunjin Yum, S. Shin, Hakje Yoo, Yong Hyun Kim, Eung Ju Kim, G. Lip, H. J. Joo
Background Improved prediction of atrial fibrillation (AF) may allow for earlier interventions for stroke prevention, as well as mortality and morbidity from other AF‐related complications. We developed a clinically feasible and accurate AF prediction model using electronic health records and computerized ECG interpretation. Methods and Results A total of 671 318 patients were screened from 3 tertiary hospitals. After careful exclusion of cases with missing values and a prior AF diagnosis, AF prediction models were developed from the derivation cohort of 25 584 patients without AF at baseline. In the internal/external validation cohort of 117 523 patients, the model using 6 clinical features and 5 ECG diagnoses showed the highest performance for 3‐year new‐onset AF prediction (C‐statistic, 0.796 [95% CI, 0.785–0.806]). A more simplified model using age, sex, and 5 ECG diagnoses (atrioventricular block, fusion beats, marked sinus arrhythmia, supraventricular premature complex, and wide QRS complex) had comparable predictive power (C‐statistic, 0.777 [95% CI, 0.766–0.788]). The simplified model showed a similar or better predictive performance than the previous models. In the subgroup analysis, the models performed relatively better in patients without risk factors. Specifically, the predictive power was lower in patients with heart failure or decreased renal function. Conclusions Although the 3‐year AF prediction model using both clinical and ECG variables showed the highest performance, the simplified model using age, sex, and 5 ECG diagnoses also had a comparable prediction power with broad applicability for incident AF.
背景改进房颤(AF)的预测可能允许早期干预预防卒中,以及其他房颤相关并发症的死亡率和发病率。我们开发了一种临床可行和准确的房颤预测模型,使用电子健康记录和计算机心电解释。方法与结果从3所三级医院筛选患者671 318例。在仔细排除缺失值的病例和先前的房颤诊断后,从25584例基线时无房颤的衍生队列中建立房颤预测模型。在117523例患者的内部/外部验证队列中,采用6个临床特征和5个心电图诊断的模型在预测3年新发房颤方面表现出最高的性能(C统计量为0.796 [95% CI, 0.785-0.806])。一个使用年龄、性别和5种心电图诊断(房室传导阻滞、融合心跳、明显的窦性心律失常、室上过早复合体和宽QRS复合体)的简化模型具有相当的预测能力(C‐统计值为0.777 [95% CI, 0.766-0.788])。简化模型的预测性能与之前的模型相似或更好。在亚组分析中,模型在没有危险因素的患者中表现相对较好。具体来说,心力衰竭或肾功能下降的患者的预测能力较低。结论:虽然使用临床和ECG变量的3年房颤预测模型表现出最高的性能,但使用年龄、性别和5种ECG诊断的简化模型也具有相当的预测能力,对房颤事件具有广泛的适用性。
{"title":"Development and Validation of 3‐Year Atrial Fibrillation Prediction Models Using Electronic Health Record With or Without Standardized Electrocardiogram Diagnosis and a Performance Comparison Among Models","authors":"Yunjin Yum, S. Shin, Hakje Yoo, Yong Hyun Kim, Eung Ju Kim, G. Lip, H. J. Joo","doi":"10.1161/JAHA.121.024045","DOIUrl":"https://doi.org/10.1161/JAHA.121.024045","url":null,"abstract":"Background Improved prediction of atrial fibrillation (AF) may allow for earlier interventions for stroke prevention, as well as mortality and morbidity from other AF‐related complications. We developed a clinically feasible and accurate AF prediction model using electronic health records and computerized ECG interpretation. Methods and Results A total of 671 318 patients were screened from 3 tertiary hospitals. After careful exclusion of cases with missing values and a prior AF diagnosis, AF prediction models were developed from the derivation cohort of 25 584 patients without AF at baseline. In the internal/external validation cohort of 117 523 patients, the model using 6 clinical features and 5 ECG diagnoses showed the highest performance for 3‐year new‐onset AF prediction (C‐statistic, 0.796 [95% CI, 0.785–0.806]). A more simplified model using age, sex, and 5 ECG diagnoses (atrioventricular block, fusion beats, marked sinus arrhythmia, supraventricular premature complex, and wide QRS complex) had comparable predictive power (C‐statistic, 0.777 [95% CI, 0.766–0.788]). The simplified model showed a similar or better predictive performance than the previous models. In the subgroup analysis, the models performed relatively better in patients without risk factors. Specifically, the predictive power was lower in patients with heart failure or decreased renal function. Conclusions Although the 3‐year AF prediction model using both clinical and ECG variables showed the highest performance, the simplified model using age, sex, and 5 ECG diagnoses also had a comparable prediction power with broad applicability for incident AF.","PeriodicalId":17189,"journal":{"name":"Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74865346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Hypertension and Diabetes Status by Patterns of Stress in Older Adults From the US Health and Retirement Study: A Latent Class Analysis 美国健康与退休研究中老年人压力模式对高血压和糖尿病状况的影响:一项潜在分类分析
Jessica Fernandez, F. A. Montiel Ishino, Faustine Williams, N. Slopen, Allana T. Forde
Background Hypertension and diabetes disproportionately affect older non‐Hispanic Black and Hispanic adults in the United States. Chronic stress may partially explain these disparities. This study identified underlying stress profiles of older US adults, analyzed stress profiles in relation to hypertension and diabetes, examined the distribution of stress profiles by race and ethnicity, and assessed patterns of change in latent classes of stress over time. Methods and Results Latent class analysis was conducted with a nationally representative sample of older US adults who completed 3 waves of the HRS (Health and Retirement Study) (ie, 2010 [n=6863], 2014 [n=4995], and 2018 [n=3089]). Latent classes of stress in 2010 (ie, stress profiles) were identified using 15 indicators of unmet needs within 5 categories (ie, physiological, safety/security, belonging, esteem, and self‐fulfillment). Hypertension and diabetes status were examined as outcomes of latent class membership at 3 time points, and race and ethnicity were examined in association with class membership, adjusting for sociodemographic covariates. Finally, a latent transition analysis examined the stability of latent class membership and racial and ethnic differences in the patterns of stress profiles experienced from 2010 to 2018. Five classes were identified: Generally Unmet Needs (13% of sample), Generally Met Needs (42% of sample), Unmet Self‐Efficacy/Goal Needs (12% of sample), Unmet Financial Needs (20% of sample), and Unmet Social Belonging Needs (13% of sample). Compared with the Generally Met Needs class, the Generally Unmet Needs class had higher odds of hypertension (odds ratio [OR], 1.80; [95% CI, 1.35–2.39]) and diabetes (OR, 1.94; [95% CI, 1.45–2.59]), and the Unmet Financial Needs class had higher odds of diabetes (OR, 1.50; [95% CI, 1.10–2.05]). Non‐Hispanic Black participants compared with non‐Hispanic White participants had higher odds of being members of the Generally Unmet Needs, Unmet Self‐Efficacy/Goal Needs, and Unmet Financial Needs classes (OR, 2.70; [95% CI, 1.59–4.58]; OR, 1.99; [95% CI, 1.15–3.43]; and OR, 4.74; [95% CI, 3.32–6.76], respectively). Class membership remained relatively stable over time, with 93% of participants remaining in Generally Met Needs and 78% of participants remaining in Generally Unmet Needs across time points. Compared with non‐Hispanic White participants, non‐Hispanic Black participants had lower odds of Generally Met Needs class membership at any time point (OR, 0.60; [95% CI, 0.42–0.84]) and had lower odds of moving into the Generally Met Needs class and higher odds of moving into the Unmet Financial Needs class from 2010 to 2014 (OR, 0.33; [95% CI, 0.13–0.86]; and OR, 3.02; [95% CI, 1.16–7.87], respectively). Conclusions Underlying classes of stress based on unmet needs were associated with hypertension and diabetes status. Racial and ethnic differences were observed for both latent class membership and transitions between classes ov
背景:在美国,高血压和糖尿病不成比例地影响着非西班牙裔黑人和西班牙裔老年人。慢性压力可能部分解释了这些差异。本研究确定了美国老年人的潜在压力概况,分析了与高血压和糖尿病相关的压力概况,检查了压力概况的种族和民族分布,并评估了潜在压力类别随时间的变化模式。方法和结果对完成了三波HRS(健康与退休研究)的美国老年人全国代表性样本(即2010年[n=6863]、2014年[n=4995]和2018年[n=3089])进行了潜在类别分析。2010年的潜在压力类别(即压力概况)使用5类(即生理、安全/保障、归属、尊重和自我实现)中未满足需求的15个指标来确定。在3个时间点检查高血压和糖尿病状况作为潜在阶层成员的结果,并检查种族和民族与阶层成员的关系,调整社会人口学协变量。最后,一项潜在转变分析检验了2010年至2018年潜在阶级成员的稳定性以及种族和民族在压力剖面模式中的差异。确定了五个类别:一般未满足的需求(占样本的13%),一般未满足的需求(占样本的42%),未满足的自我效能/目标需求(占样本的12%),未满足的财务需求(占样本的20%)和未满足的社会归属需求(占样本的13%)。与一般满足需求组相比,一般未满足需求组患高血压的几率更高(比值比[OR], 1.80;[95% CI, 1.35-2.39])和糖尿病(OR, 1.94;[95% CI, 1.45-2.59]),未满足财务需求的人群患糖尿病的几率更高(OR, 1.50;[95% ci, 1.10-2.05])。非西班牙裔黑人参与者与非西班牙裔白人参与者相比,成为“一般未满足需求”、“未满足自我效能/目标需求”和“未满足财务需求”类别成员的几率更高(OR, 2.70;[95% ci, 1.59-4.58];或者,1.99;[95% ci, 1.15-3.43];OR为4.74;[95% CI, 3.32-6.76])。随着时间的推移,班级成员保持相对稳定,93%的参与者保持在“基本满足需求”,78%的参与者保持在“基本未满足需求”。与非西班牙裔白人参与者相比,非西班牙裔黑人参与者在任何时间点都有较低的“基本满足需求”班级成员的几率(OR, 0.60;[95% CI, 0.42-0.84]),从2010年到2014年,进入一般满足需求类别的几率较低,进入未满足金融需求类别的几率较高(OR, 0.33;[95% ci, 0.13-0.86];OR = 3.02;[95% CI, 1.16-7.87])。结论:基于未满足需求的潜在应激等级与高血压和糖尿病状态相关。随着时间的推移,在潜在的阶级成员和阶级之间的转变上观察到种族和民族的差异。与未满足需求、高血压和糖尿病相关的潜在压力等级以及在等级之间转换的能力可能解释了心血管健康中种族和民族差异的持续存在。针对未满足需求的干预措施可用于应对这些差异。
{"title":"Hypertension and Diabetes Status by Patterns of Stress in Older Adults From the US Health and Retirement Study: A Latent Class Analysis","authors":"Jessica Fernandez, F. A. Montiel Ishino, Faustine Williams, N. Slopen, Allana T. Forde","doi":"10.1161/JAHA.121.024594","DOIUrl":"https://doi.org/10.1161/JAHA.121.024594","url":null,"abstract":"Background Hypertension and diabetes disproportionately affect older non‐Hispanic Black and Hispanic adults in the United States. Chronic stress may partially explain these disparities. This study identified underlying stress profiles of older US adults, analyzed stress profiles in relation to hypertension and diabetes, examined the distribution of stress profiles by race and ethnicity, and assessed patterns of change in latent classes of stress over time. Methods and Results Latent class analysis was conducted with a nationally representative sample of older US adults who completed 3 waves of the HRS (Health and Retirement Study) (ie, 2010 [n=6863], 2014 [n=4995], and 2018 [n=3089]). Latent classes of stress in 2010 (ie, stress profiles) were identified using 15 indicators of unmet needs within 5 categories (ie, physiological, safety/security, belonging, esteem, and self‐fulfillment). Hypertension and diabetes status were examined as outcomes of latent class membership at 3 time points, and race and ethnicity were examined in association with class membership, adjusting for sociodemographic covariates. Finally, a latent transition analysis examined the stability of latent class membership and racial and ethnic differences in the patterns of stress profiles experienced from 2010 to 2018. Five classes were identified: Generally Unmet Needs (13% of sample), Generally Met Needs (42% of sample), Unmet Self‐Efficacy/Goal Needs (12% of sample), Unmet Financial Needs (20% of sample), and Unmet Social Belonging Needs (13% of sample). Compared with the Generally Met Needs class, the Generally Unmet Needs class had higher odds of hypertension (odds ratio [OR], 1.80; [95% CI, 1.35–2.39]) and diabetes (OR, 1.94; [95% CI, 1.45–2.59]), and the Unmet Financial Needs class had higher odds of diabetes (OR, 1.50; [95% CI, 1.10–2.05]). Non‐Hispanic Black participants compared with non‐Hispanic White participants had higher odds of being members of the Generally Unmet Needs, Unmet Self‐Efficacy/Goal Needs, and Unmet Financial Needs classes (OR, 2.70; [95% CI, 1.59–4.58]; OR, 1.99; [95% CI, 1.15–3.43]; and OR, 4.74; [95% CI, 3.32–6.76], respectively). Class membership remained relatively stable over time, with 93% of participants remaining in Generally Met Needs and 78% of participants remaining in Generally Unmet Needs across time points. Compared with non‐Hispanic White participants, non‐Hispanic Black participants had lower odds of Generally Met Needs class membership at any time point (OR, 0.60; [95% CI, 0.42–0.84]) and had lower odds of moving into the Generally Met Needs class and higher odds of moving into the Unmet Financial Needs class from 2010 to 2014 (OR, 0.33; [95% CI, 0.13–0.86]; and OR, 3.02; [95% CI, 1.16–7.87], respectively). Conclusions Underlying classes of stress based on unmet needs were associated with hypertension and diabetes status. Racial and ethnic differences were observed for both latent class membership and transitions between classes ov","PeriodicalId":17189,"journal":{"name":"Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74121496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Active RhoA Exerts an Inhibitory Effect on the Homeostasis and Angiogenic Capacity of Human Endothelial Cells 活性RhoA对人内皮细胞的稳态和血管生成能力有抑制作用
Michael Hauke, Robert Eckenstaler, A. Ripperger, Anna Ender, Heike Braun, R. Benndorf
Background The small GTPase RhoA (Ras homolog gene family, member A) regulates a variety of cellular processes, including cell motility, proliferation, survival, and permeability. In addition, there are reports indicating that RhoA‐ROCK (rho associated coiled‐coil containing protein kinase) activation is essential for VEGF (vascular endothelial growth factor)‐mediated angiogenesis, whereas other work suggests VEGF‐antagonistic effects of the RhoA‐ROCK axis. Methods and Results To elucidate this issue, we examined human umbilical vein endothelial cells and human coronary artery endothelial cells after stable overexpression (lentiviral transduction) of constitutively active (G14V/Q63L), dominant‐negative (T19N), or wild‐type RhoA using a series of in vitro angiogenesis assays (proliferation, migration, tube formation, angiogenic sprouting, endothelial cell viability) and a human umbilical vein endothelial cells xenograft assay in immune‐incompetent NOD scid gamma mice in vivo. Here, we report that expression of active and wild‐type RhoA but not dominant‐negative RhoA significantly inhibited endothelial cell proliferation, migration, tube formation, and angiogenic sprouting in vitro. Moreover, active RhoA increased endothelial cell death in vitro and decreased human umbilical vein endothelial cell‐related angiogenesis in vivo. Inhibition of RhoA by C3 transferase antagonized the inhibitory effects of RhoA and strongly enhanced VEGF‐induced angiogenic sprouting in control‐treated cells. In contrast, inhibition of RhoA effectors ROCK1/2 and LIMK1/2 (LIM domain kinase 1/2) did not significantly affect RhoA‐related effects, but increased angiogenic sprouting and migration of control‐treated cells. In agreement with these data, VEGF did not activate RhoA in human umbilical vein endothelial cells as measured by a Förster resonance energy transfer–based biosensor. Furthermore, global transcriptome and subsequent bioinformatic gene ontology enrichment analyses revealed that constitutively active RhoA induced a differentially expressed gene pattern that was enriched for gene ontology biological process terms associated with mitotic nuclear division, cell proliferation, cell motility, and cell adhesion, which included a significant decrease in VEGFR‐2 (vascular endothelial growth factor receptor 2) and NOS3 (nitric oxide synthase 3) expression. Conclusions Our data demonstrate that increased RhoA activity has the potential to trigger endothelial dysfunction and antiangiogenic effects independently of its well‐characterized downstream effectors ROCK and LIMK.
小GTPase RhoA (Ras同源基因家族,成员A)调节多种细胞过程,包括细胞运动、增殖、存活和通透性。此外,有报道表明RhoA‐ROCK(含rho相关卷曲蛋白激酶)的激活对于VEGF(血管内皮生长因子)介导的血管生成至关重要,而其他研究表明RhoA‐ROCK轴具有VEGF拮抗作用。方法和结果为了阐明这一问题,我们使用一系列体外血管生成实验(增殖、迁移、管形成、血管生成发芽、生长、生长)检测了组成型活性(G14V/Q63L)、显性阴性(T19N)或野生型RhoA稳定过表达(慢病毒转导)后的人脐静脉内皮细胞和冠状动脉内皮细胞。内皮细胞活力)和人脐静脉内皮细胞异种移植实验在免疫功能不全NOD scid γ小鼠体内进行。在这里,我们报道了活性和野生型RhoA的表达,而不是显性阴性RhoA的表达,显著抑制了内皮细胞的增殖、迁移、管形成和体外血管新生芽。此外,活性RhoA在体外增加内皮细胞死亡,并在体内减少人脐静脉内皮细胞相关的血管生成。C3转移酶抑制RhoA可拮抗RhoA的抑制作用,并在对照处理的细胞中强烈增强VEGF诱导的血管新生芽。相比之下,抑制RhoA效应物ROCK1/2和LIMK1/2 (LIM结构域激酶1/2)对RhoA相关效应没有显著影响,但增加了对照处理细胞的血管生成发芽和迁移。与这些数据一致的是,通过Förster共振能量转移生物传感器测量,VEGF不会激活人脐静脉内皮细胞中的RhoA。此外,全球转录组和随后的生物信息学基因本体富集分析显示,组成型活性RhoA诱导了一种差异表达的基因模式,该基因模式富集了与有丝分裂核分裂、细胞增殖、细胞运动和细胞粘附相关的基因本体生物学过程术语,其中包括VEGFR‐2(血管内皮生长因子受体2)和NOS3(一氧化氮合酶3)表达的显著降低。结论:我们的数据表明,RhoA活性的增加有可能引发内皮功能障碍和抗血管生成作用,而不依赖于其下游效应物ROCK和LIMK。
{"title":"Active RhoA Exerts an Inhibitory Effect on the Homeostasis and Angiogenic Capacity of Human Endothelial Cells","authors":"Michael Hauke, Robert Eckenstaler, A. Ripperger, Anna Ender, Heike Braun, R. Benndorf","doi":"10.1161/JAHA.121.025119","DOIUrl":"https://doi.org/10.1161/JAHA.121.025119","url":null,"abstract":"Background The small GTPase RhoA (Ras homolog gene family, member A) regulates a variety of cellular processes, including cell motility, proliferation, survival, and permeability. In addition, there are reports indicating that RhoA‐ROCK (rho associated coiled‐coil containing protein kinase) activation is essential for VEGF (vascular endothelial growth factor)‐mediated angiogenesis, whereas other work suggests VEGF‐antagonistic effects of the RhoA‐ROCK axis. Methods and Results To elucidate this issue, we examined human umbilical vein endothelial cells and human coronary artery endothelial cells after stable overexpression (lentiviral transduction) of constitutively active (G14V/Q63L), dominant‐negative (T19N), or wild‐type RhoA using a series of in vitro angiogenesis assays (proliferation, migration, tube formation, angiogenic sprouting, endothelial cell viability) and a human umbilical vein endothelial cells xenograft assay in immune‐incompetent NOD scid gamma mice in vivo. Here, we report that expression of active and wild‐type RhoA but not dominant‐negative RhoA significantly inhibited endothelial cell proliferation, migration, tube formation, and angiogenic sprouting in vitro. Moreover, active RhoA increased endothelial cell death in vitro and decreased human umbilical vein endothelial cell‐related angiogenesis in vivo. Inhibition of RhoA by C3 transferase antagonized the inhibitory effects of RhoA and strongly enhanced VEGF‐induced angiogenic sprouting in control‐treated cells. In contrast, inhibition of RhoA effectors ROCK1/2 and LIMK1/2 (LIM domain kinase 1/2) did not significantly affect RhoA‐related effects, but increased angiogenic sprouting and migration of control‐treated cells. In agreement with these data, VEGF did not activate RhoA in human umbilical vein endothelial cells as measured by a Förster resonance energy transfer–based biosensor. Furthermore, global transcriptome and subsequent bioinformatic gene ontology enrichment analyses revealed that constitutively active RhoA induced a differentially expressed gene pattern that was enriched for gene ontology biological process terms associated with mitotic nuclear division, cell proliferation, cell motility, and cell adhesion, which included a significant decrease in VEGFR‐2 (vascular endothelial growth factor receptor 2) and NOS3 (nitric oxide synthase 3) expression. Conclusions Our data demonstrate that increased RhoA activity has the potential to trigger endothelial dysfunction and antiangiogenic effects independently of its well‐characterized downstream effectors ROCK and LIMK.","PeriodicalId":17189,"journal":{"name":"Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80458402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1